Recruiting Rett Syndrome Studies in Dallas
Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
The REVEAL Pediatric Study is a multi-center, Phase 1/2 open-label, dose-escalation and dose-expansion study of TSHA-102, an investigational gene therapy, in pediatric females with Rett Syndrome. The...
Safety and Efficacy of TSHA-102 in Adolescent and Adult Females With Rett Syndrome (REVEAL Adult Study)
The REVEAL Adult Study is a multi-center, Phase 1/2 open-label, dose-escalation study of TSHA-102, an investigational gene therapy, in adult females with Rett syndrome. The safety, tolerability, and p...
About Rett Syndrome Clinical Trials in Dallas
Rett syndrome is a rare genetic neurological disorder that primarily affects girls, causing a regression in development after initially normal growth. It is caused by mutations in the MECP2 gene. Treatment is supportive, with gene therapies under investigation.
There are currently 2 rett syndrome clinical trials recruiting participants in Dallas, TEXAS. These studies are seeking a combined 38 participants. Research is being sponsored by Taysha Gene Therapies, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Rett Syndrome Clinical Trials in Dallas — FAQ
Are there rett syndrome clinical trials in Dallas?
Yes, there are 2 rett syndrome clinical trials currently recruiting in Dallas, TEXAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dallas?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.
Are clinical trials in Dallas free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.
What rett syndrome treatments are being tested?
The 2 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for rett syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov